FDA Simplifies Biosimilar Approvals; Patents And Payment Issues Remain

Biosimilars is a biologic medication that is highly similar to an already approved reference product. It has no clinically meaningful differences in terms of safety, purity, and potency compared to the reference product. As lower-priced versions…